XNAS
OSIS
Market cap3.11bUSD
Oct 20, Last price
194.86USD
1D
0.46%
1Q
-7.12%
Jan 2017
155.99%
Name
OSI Systems Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
OSI Systems, Inc. (OSIS) is a global company specializing in the design and production of advanced electronic systems and components. Its operations are structured across three distinct business segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security division focuses on comprehensive screening and detection technologies. This includes systems for inspecting luggage, packages, cargo, vehicles, and individuals, alongside solutions for radiation, explosive, and narcotics detection. Key product lines are marketed under names such as Rapiscan Systems, AS&E, and Gatekeeper. Beyond hardware, the segment delivers integrated security screening services, including site planning, installation, user training, and ongoing technical support, with dedicated solutions offered via the S2 brand. Within the Healthcare segment, the company provides patient monitoring and diagnostic cardiology systems, complete with necessary supplies and accessories. These critical care solutions, branded predominantly as Spacelabs, are deployed in a range of medical environments, including hospitals (specifically critical care, emergency rooms, and surgical areas), physicians' offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing segment supplies various optoelectronic devices, marketed under brand names such as OSI Optoelectronics, OSI LaserDiode, OSI Laserscan, Semicoa, and Advanced Photonix. These devices cater to diverse high-tech sectors including aerospace, defense, avionics, medical imaging and diagnostics, biochemical analysis, pharmaceuticals, nanotechnology, telecommunications, construction, and homeland security. Additionally, it provides electronics manufacturing services (EMS) to both original equipment manufacturers (OEMs) and direct end-users, serving applications in medical, automotive, defense, aerospace, industrial, and consumer sectors through brands like OSI Electronics, APlus Products, Altaflex, and PFC. This segment also produces LCD displays for medical, industrial, and consumer electronics, along with flexible circuits tailored for OEM clients. Further expanding its offerings, the segment develops laser-based remote sensing technology, notably under the OSI Laserscan and Autosense brands, to identify and categorize vehicles in toll collection and traffic management systems. It also manufactures solid-state laser products, specifically for aerospace, defense, telecommunications, and medical applications, marketed under the OSI LaserDiode name. Established in 1987, OSI Systems is headquartered in Hawthorne, California.
Key people
Wilson Constantine
President - Spacelabs Healthcare · since 2025
Ajay Mehra
President, Chief Executive Officer, Director · since 2025
Shalabh Chandra
President - Healthcare Division · since 2019
Paul Morben
President - OSI Electronics · since 2019
Michael Tropeano
President of Rapiscan · since 2025
Glenn Grindstaff
Chief Human Resources Officer, Senior Vice President · since 2020
Alan Edrick
Chief Financial Officer, Executive Vice President · since 2006
Cary Okawa
Chief Accounting Officer · since 2024
Deepak Chopra
Executive Chairman of the Board · since 2025
Manoocher Mansouri
Chief Technology Officer - Optoelectronics and Manufacturing Division · since 2025
Victor Sze
Executive Vice President, General Counsel, Secretary · since 2004
William Ballhaus
Lead Independent Director · since 2019
Kelli Bernard
Independent Director · since 2019
Gerald Chizever
Independent Director · since 2016
Independent Director · since 2015
Independent Director · since 2019
Legal address
C/O THE CORPORATION TRUST COMPANY
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
CORPORATION TRUST CENTER
1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
12525 Chadron Avenue
Hawthorne, CA 90250
US
Hawthorne, CA 90250
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||